The importance of PCSK9 for LDL-c homeostasis was further highlighted when it was discovered that PCSK9 loss- and gain-of-function mutations cause hypo- or hypercholesterolemia in patients with devastating risks for atherosclerotic cardiovascular disease and its progression [11,12]. Here, PCSK9 is linked to familial hypercholesterolemia.